DH~270 nm; modification of vesicles with thiol-functionalized folic acid; triggered CP release in acidic conditions (pH 5); dose-dependent cytotoxicity towards cancer cells compared to normal cells; higher cellular uptake of FA-modified vesicles. This evidence concerns the gene CP and cancer.